Alpha Paradigm Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$251K Sell
456
-112
-20% -$59.3K 0.1% 281
2022
Q3
$288K Buy
+568
New +$318K 0.13% 246
2022
Q2
Sell
-647
Closed -$382K 635
2022
Q1
$382K Buy
+647
New +$372K 0.15% 227
2021
Q4
Sell
-2,863
Closed -$1.64M 670
2021
Q3
$1.64M Buy
+2,863
New +$1.57M 0.66% 27

Other funds holding TMO

Alpha Paradigm Partners's TMO Position: Q4 2022 in Review

Alpha Paradigm Partners reduced its Thermo Fisher Scientific (TMO) stake by 20% in Q4 2022, selling an estimated $59.3K and leaving 456 shares worth $251K. The position accounts for 0.1% of the portfolio, ranked #281.

Alpha Paradigm Partners first reported a position in TMO in Q3 2021 and has held it in 4 quarters since. The position peaked at $1.64M in Q3 2021. 2,374 funds tracked by Wall St. Rank hold TMO as of Q4 2022.

  • Alpha Paradigm Partners held 456 shares of Thermo Fisher Scientific worth $251K as of Q4 2022.
  • Alpha Paradigm Partners sold 112 Thermo Fisher Scientific shares in Q4 2022, an estimated $59.3K.
  • Thermo Fisher Scientific made up 0.1% of Alpha Paradigm Partners's portfolio in Q4 2022, its #281 holding.
  • Alpha Paradigm Partners first reported a position in Thermo Fisher Scientific in Q3 2021 and has held it in 4 quarters since.
  • Alpha Paradigm Partners's Thermo Fisher Scientific position peaked at $1.64M in Q3 2021.
  • 2,374 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2022.

Based on Alpha Paradigm Partners's 13F filing for Q4 2022, filed 13 Feb 2023.